AT308926T

Peracetic acid crosslinked non-antigenic icl grafts

Abstract

This invention relates to prosthesis, when implanted in a patient mammal, SERVE AS A REPLACEMENT FOR FUNCTIONAL body part or tissue structure, and suffer Biodegradation CONTROLLED TO BE HELD WITH A RESTRUCTURING BY Concomitantly Living Cells PATIENT. Denture IS SO BECOMES nonantigenic WITH THE AIM OF NO SIGNIFICANT elicit an immune response humoral response. The prosthesis of this invention, in its various embodiments, THUS HAS DUAL PROPERTIES. FIRST, IT WORKS AS A SUBSTITUTE FOR A PART OF THE BODY, AND AS A SECOND PLACE IT WORKS FOR MOLD BIORREESTRUCTURACION ingrowth host cells.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

27 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
41786895United States of AmericaA
9603336United States of AmericaW

Members27

Family members, oldest first
DocumentOfficeKind
CA2217581A1CanadaA1
WO9631157A1World Intellectual Property Organization (WIPO)A1
AU5308396AAustraliaA
MX9707655AMexicoA
EP0828453A1European Patent Office (EPO)A1
US5733337AUnited States of AmericaA
JPH11503051AJapanA
AU711900B2AustraliaB2
EP0828453A4European Patent Office (EPO)A4
US2002095218A1United States of AmericaA1
US2003158607A1United States of AmericaA1
JP2004267791AJapanA
EP0828453B1European Patent Office (EPO)B1
AT308926TThis recordAustriaT
ATE308926T1AustriaT1
DE69635414D1GermanyD1
EP1623681A1European Patent Office (EPO)A1
JP3756187B2JapanB2
ES2252753T3SpainT3
US7060103B2United States of AmericaB2
US2006173471A1United States of AmericaA1
DE69635414T2GermanyT2
US7909886B2United States of AmericaB2
CA2217581CCanadaC
JP2012101100AJapanA
EP1623681B1European Patent Office (EPO)B1
ES2426668T3SpainT3